miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and SRC
Cancer Research - United States
doi 10.1158/0008-5472.can-14-0795
Full Text
Open PDFAbstract
Available in full text
Date
November 16, 2015
Authors
Publisher
American Association for Cancer Research (AACR)